![]() |
Volumn 358, Issue 6366, 2017, Pages 1019-1027
|
RNA editing with CRISPR-Cas13
a,b,c
a,b,c,d
a,b,c
c
USA
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEAMINASE;
GUIDE RNA;
MESSENGER RNA;
MITOGEN ACTIVATED PROTEIN KINASE;
RNA;
TRANSCRIPTOME;
ADENOSINE DEAMINASE;
BACTERIAL PROTEIN;
ENDONUCLEASE;
HYBRID PROTEIN;
BIOTECHNOLOGY;
CATALYSIS;
CELLS AND CELL COMPONENTS;
DISEASE TREATMENT;
ENZYME;
ENZYME ACTIVITY;
MUTATION;
NUCLEIC ACID;
PROTEIN;
RESEARCH WORK;
RNA;
ARTICLE;
BIOTECHNOLOGY;
CELLULAR DISTRIBUTION;
CODON;
CONTROLLED STUDY;
CRISPR CAS SYSTEM;
CRISPR CAS13 SYSTEM;
DNA STRAND;
ENZYME SPECIFICITY;
GENE EXPRESSION;
GENE MUTATION;
HEK293-FT CELL LINE;
HUMAN;
HUMAN CELL;
LEPTOTRICHIA;
LUCIFERASE ASSAY;
MAMMAL CELL;
MUTAGENESIS;
NONHUMAN;
NUCLEAR EXPORT;
ORTHOLOGY;
PORPHYROMONAS;
PREVOTELLA;
PRIORITY JOURNAL;
PROTEIN ENGINEERING;
RNA BINDING;
RNA EDITING;
RNA SEQUENCE;
CLASSIFICATION;
FANCONI ANEMIA;
GENE KNOCKDOWN;
GENE THERAPY;
GENETICS;
HEK293 CELL LINE;
METABOLISM;
NEPHROGENIC DIABETES INSIPIDUS;
PROCEDURES;
MAMMALIA;
ADENOSINE DEAMINASE;
BACTERIAL PROTEINS;
BIOTECHNOLOGY;
CRISPR-CAS SYSTEMS;
DIABETES INSIPIDUS, NEPHROGENIC;
ENDONUCLEASES;
FANCONI ANEMIA;
GENE KNOCKDOWN TECHNIQUES;
GENETIC THERAPY;
HEK293 CELLS;
HUMANS;
MUTAGENESIS;
PROTEIN ENGINEERING;
RECOMBINANT FUSION PROTEINS;
RNA EDITING;
|
EID: 85032331429
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aaq0180 Document Type: Article |
Times cited : (1233)
|
References (32)
|